Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net loss $ (125,170) $ (156,468)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation expense 1,853 2,286
(Gain) loss on sale of property and equipment (1,351) 255
Bad debt expense 492 10
Amortization of debt discount 2,524 1,500
Accretion of partner company convertible preferred shares 687 0
Non-cash interest 353 619
Loss on extinguishment of debt 2,796 0
Amortization of acquired intangible assets 2,952 3,050
Reduction in the carrying amount of operating lease right-of-use assets 1,561 1,425
Stock-based compensation expense 13,325 17,481
Issuance (reversal) of partner company's common shares for research and development expenses 1,233 (27)
Common shares issued/issuable for dividend on partner company's convertible preferred shares 199 0
Change in fair value of partner companies' warrant liabilities (10,708) 0
Research and development - licenses acquired, expense 3,060 40
Loss from deconsolidation/dissolution of subsidiaries 4,127 0
Asset impairment loss 3,143 0
Increase (decrease) in cash and cash equivalents resulting from changes in operating assets and liabilities:    
Accounts receivable 19,727 (5,431)
Inventory 3,135 673
Other receivables - related party (27) 525
Prepaid expenses and other current assets 3,217 1,339
Other assets (1,107) (77)
Accounts payable and accrued expenses (17,018) 4,410
Deferred revenue 0 (1,518)
Income taxes payable 84 13
Lease liabilities (1,739) (1,522)
Other long-term liabilities (638) (140)
Net cash used in operating activities (93,290) (131,557)
Cash Flows from Investing Activities:    
Purchase of research and development licenses (3,000) (40)
Purchase of property and equipment (35) (2,624)
Proceeds from sale of property and equipment 6,000 127
Other 5 0
Acquired intangible assets (5,000) (20,000)
Net cash used in investing activities (2,040) (22,537)
Cash Flows from Financing Activities:    
Payment of Series A perpetual preferred stock dividends (6,024) (6,024)
Proceeds from issuance of common stock for public offering, net 13,248 0
Proceeds from issuance of common stock for at-the-market offering, net 2,056 5,750
Proceeds from issuance of common stock under ESPP 0 99
Proceeds from partner companies' ESPP 178 206
Partner company's dividends declared and paid (556) (563)
Proceeds from partner companies' sale of stock and warrants, net 33,805 (371)
Proceeds from partner companies' at-the-market offering, net 160 16,193
Proceeds from exercise of partner companies' equity grants 24 142
Partner company's net settlement of shares withheld for taxes 0 (1,698)
Payment of partner company's deferred financing cost 0 (119)
Repayment of partner company installment payments - licenses (1,000) (3,000)
Proceeds from partner company convertible preferred shares 854 0
Payment of debt issuance costs associated with partner company convertible preferred shares (210) (214)
(Repayment of) Proceeds from partner company long-term debt, net (91) 47,112
Repayment of partner company long-term debt (50,375) 0
Proceeds from partner company's line of credit 28,000 0
Repayment of partner company's line of credit (30,948) (812)
Net cash (used in) provided by financing activities (10,879) 56,701
Net decrease in cash and cash equivalents and restricted cash (106,209) (97,393)
Cash and cash equivalents and restricted cash at beginning of period 180,954 307,964
Cash and cash equivalents and restricted cash at end of period 74,745 210,571
Supplemental disclosure of cash flow information:    
Cash paid for interest 6,590 6,595
Cash paid (refunded) for income taxes (17) 1,462
Supplemental disclosure of non-cash financing and investing activities:    
Settlement of restricted stock units into common stock 0 3
Unpaid fixed assets 0 21
Partner company's unpaid intangible assets 0 4,740
Unpaid partner company's debt offering cost 0 1,050
Unpaid partner company's offering cost 575 0
Partner company derivative warrant liability associated with partner company convertible preferred shares 33 0
Warrants 0 384
Unpaid at-the-market offering cost 50 0
Prepaid public offering cost 94 0
Unpaid research and development licenses acquired $ 60 $ 0